NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
November 5, 2019
The FDA has approved Raleigh-based RedHill Biopharma’s new drug to treat serious gastrointestinal infections after a priority review of the medication.
November 5, 2019
BioAgilytix, a Durham-based provider of large-molecule bioanalytical testing services, has acquired Cambridge Biomedical, a contract research organization based in the Boston suburb of Cambridge.
October 30, 2019
A unique, non-invasive urine test to diagnose cancers in dogs will soon get more “legs” in the marketplace, thanks to a deal struck by its developer, Raleigh-based Sentinel Biomedical.
October 30, 2019
The recently expanding Novo Nordisk drug-manufacturing operations in Durham and Clayton will provide U.S. supplies of the company’s new diabetes drug Rybelsus.
October 29, 2019
Satsuma Pharmaceuticals, a South San Francisco pharmaceutical company with operations in Research Triangle Park, will use proceeds from a September $90.8 million initial public offering to develop its fast-acting, easy-to-use nasal powder inhaler formulation to treat migraine from pocket or purse.
October 29, 2019
Point Motion, a new Winston-Salem digital health company founded by a jazz musician, is using the music of movement to detect and monitor changes in wellbeing.
October 28, 2019
The North Carolina Biotechnology Center has launched a demonstration pilot program of free genetic testing for its employees in a collaboration with health technology company Color Genomics.
October 28, 2019
Durham medical device company 410 Medical has closed on an $8 million Series A financing deal with Hatteras Venture Partners, OSF Healthcare and former investors.
October 24, 2019
TriPharm Services, a new Morrisville-based contract pharmaceutical development and manufacturing organization, is commissioning a new specialized manufacturing operation using the latest isolator manufacturing equipment.
October 23, 2019
After more than two decades of game-changing accomplishments in the life science world, AskBio CEO Sheila Mikhail has been “discovered” as the Springboard Enterprises 2019 Northstar Honoree.
October 23, 2019
For the third time since opening a Charlotte R&D and manufacturing facility in 2012, medical device company Medical Murray is celebrating the opening of an even bigger “home” in the Queen City – this one encompassing 30,000 square feet.
October 23, 2019
Three early stage bioscience companies in North Carolina are among 16 companies from the Southeast selected to present their funding needs to potential investors at a major industry conference next month in Florida.
October 22, 2019
Mycovia Pharmaceuticals of Durham is partnering with a major Hungarian pharmaceutical company to commercialize and manufacture one of Mycovia’s drug candidates in Europe, Latin America, Australia, Russia and other former Soviet countries.
October 22, 2019
Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has commercially launched Duaklir, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), in the United States.
October 17, 2019
Over 120 life science professionals in the race for new therapies for rare disease gathered for a full late-September day of speakers, panels, audience engagement and networking at the Rare Disease Forum at the North Carolina Biotechnology Center.